Volume 27, Issue 4 - Patient-reported outcomes

Regulatory Matters & Regulatory Public Disclosure

Authors: Jennifer Clemens, Sam Hamilton, Jessica Williams, Kathy B. Thomas

Abstract

References

1. Brenner L. What is a symbiotic relationship? [Internet]. Sciencing. 9 Aug 2018 [cited 4 Oct 2018]. Available from: Available from: https://sciencing.com/symbioticrelationship- 8794702.html.
2. Sharma D, Lucier C, Molloy R. From solutions to symbiosis: blending with your customers. [Internet]. Strategy+Business. 9 Apr 2002 [cited 4 Oct 2018]. Available from: Available from: https://www.strategy-business.com/ article/18411?gko=1539d.
3. Smith I. The symbiotic relationship in business – complexity & simplicity. [Internet]. The Portfolio Partnership. 11 Dec 2012 [cited 4 Oct 2018]. Available from: Available from: http://portfoliopartnership.com/ the-symbiotic-relationship-in-businesscomplexity- simplicity/.
4. Thomas Kathy B. Clinical trial disclosure and transparency: Regulation EU No. 536/2014. Public disclosure at the clinical trial level. Medical Writing 27(2):7–17, 2018 Available from: http://journal.emwa.org/publicdisclosure/ clinical-trial-disclosure-andtransparency/[ accessed 2018 September].
5. Thomas KB. Clinical trial disclosure and transparency: ongoing developments on the need to disclose clinical data. In Medical writing the backbone of clinical development. International Clinical Trials. pp 63-70, 2017. Available from: http://edition.pagesuiteprofessional. co.uk/launch.aspx?eid=f6b80f6 a-ddd6-4705-bc9a-8af003f96adb [accessed 2018 September].
6. Thomas KB. Clinical Trial Disclosure and Transparency: The Medical Writer’s Perspective; in Thomas KB, Reeves A, (eds): EMWA Symposium. EMWA, 2014, pp 6–17. Available from: http://www.emwa.org/Documents/ Transparency%20Symposium%20 Budapest%20Final.pdf [accessed 2018 September].